Challenging Therapeutics IP After Fed. Circ. Drink Can Ruling

The U.S. Court of Appeals for the Federal Circuit's Dec. 31 opinion in Ball Metal Beverage Container Corp. v. Crown Packaging Technology Inc.,[1] though nonprecedential, raises important considerations for pharmaceutical and...

Already a subscriber? Click here to view full article